Results 121 to 130 of about 5,395,673 (305)

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. [PDF]

open access: yesCancers (Basel), 2022
Manzar GS   +14 more
europepmc   +1 more source

Bladder preservation by combined modality therapy for invasive bladder cancer.

open access: yes, 1997
PURPOSE To update the efficacy of a selective multimodality bladder-preserving approach by transurethral resection (TURBT), systemic chemotherapy, and radiation therapy.
N M Heney   +6 more
core   +1 more source

The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta   +11 more
wiley   +1 more source

Dyad art therapy: Birth of a modality [PDF]

open access: yes, 2016
This project investigates the early development of dyad art therapy and the publications leading to its birth and subsequent consolidation as a modality.
Dancette-de Bresson, Connie
core   +1 more source

A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. [PDF]

open access: yesBlood Adv, 2022
Chohan KL   +10 more
europepmc   +1 more source

The influence of patient-related constutional and environmental factors on early results of a combined modality therapy of esophageal cancer [PDF]

open access: yes, 2016
Among many various factors affecting the outcome of cancer treatment one can distinguish patient, tumor- and treatment-related factors. The association of patient-related factors and results of a combined modality therapy of esophageal cancer has not ...
Pudło, Kamil   +7 more
core  

Serostatus‐Specific Prognostic Profiles and Phenotype‐Dependent Therapeutic Windows in Autoimmune Encephalitis: A Multicenter Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background While autoimmune encephalitis (AE) outcomes vary, serostatus‐specific prognostic determinants and institutional clustering effects remain poorly characterized. We aimed to delineate the distinct prognostic architecture of AE, identifying serostatus‐specific risk factors and potential therapeutic windows.
Xiaohong Tang   +17 more
wiley   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

open access: yesArthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos   +2 more
wiley   +1 more source

Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy. [PDF]

open access: yesDis Colon Rectum, 2022
Taylor JP   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy